Biden’s Proposal to Cover Weight-Loss Drugs Faces Financial Concerns
The Biden administration’s push to have Medicare and Medicaid cover weight-loss drugs has sparked a debate over potential financial implications. The proposal, announced recently, aims to expand access to medications like Ozempic and Wegovy, which are currently not covered unless prescribed for diabetes or heart disease. Proposal Overview: The Biden administration proposes reclassifying obesity as a…